The landscape of dementia diagnosis has developed substantially with the arrival of innovative biomarkers, which include amyloid PET scans, tau imaging, and blood-dependent exams that will detect Alzheimer's pathology many years before indications arise. Although these technological developments represent remarkable development in knowledge neurodegenerative conditions, they've not di... https://peterq642oxh1.blogaritma.com/profile